Search research articles
Contact Us
Filters
Showing results (441-450 of 524) with videos related to
Page
of 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors
Matteo Repetto, Allison L Richards, Monica F Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2013
Small cell lung cancer
Gregory P Kalemkerian, Wallace Akerley, Paul Bogner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T Li, Ronglai Shen, Darren Buonocore, et al.
Cancer Discovery
|
August 4, 2021
Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
Metamia Ciampricotti, Triantafyllia Karakousi, Allison L Richards, et al.
Cell Reports
|
October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Anastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
JCO Precision Oncology
|
September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Cell Reports
|
April 30, 2025
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer
Alessia Catozzi, Maria Peiris Pagès, Sam Humphrey, et al.
Science Advances
|
March 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
Ray Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Cancer Cell
|
February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Barzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Clemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg, et al.
Page
of 53
Search research articles
Search
Showing results (441-450 of 524) with videos related to
Sort By:
Page
of 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors
Matteo Repetto, Allison L Richards, Monica F Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2013
Small cell lung cancer
Gregory P Kalemkerian, Wallace Akerley, Paul Bogner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T Li, Ronglai Shen, Darren Buonocore, et al.
Cancer Discovery
|
August 4, 2021
Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
Metamia Ciampricotti, Triantafyllia Karakousi, Allison L Richards, et al.
Cell Reports
|
October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Anastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
JCO Precision Oncology
|
September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Cell Reports
|
April 30, 2025
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer
Alessia Catozzi, Maria Peiris Pagès, Sam Humphrey, et al.
Science Advances
|
March 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
Ray Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Cancer Cell
|
February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Barzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Clemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg, et al.
Page
of 53